Active Ingredient History
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Communicable Diseases (Phase 3)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 4)
Critical Illness (Phase 2)
Drugs, Investigational (Phase 2/Phase 3)
Healthy Volunteers (Phase 1)
Hemorrhagic Fever, Ebola (Phase 2)
Influenza, Human (Phase 3)
Lassa Fever (Phase 2)
Liver Diseases (Phase 1)
Respiratory Distress Syndrome (Phase 1/Phase 2)
SARS-CoV-2 (Phase 2)
Severe Acute Respiratory Syndrome (Phase 3)
Therapeutic Equivalency (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue